22-41157261-C-T
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The ENST00000263253.9(EP300):c.3354C>T(p.Val1118=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00199 in 1,614,044 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V1118V) has been classified as Likely benign.
Frequency
Consequence
ENST00000263253.9 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EP300 | NM_001429.4 | c.3354C>T | p.Val1118= | synonymous_variant | 18/31 | ENST00000263253.9 | NP_001420.2 | |
EP300 | NM_001362843.2 | c.3276C>T | p.Val1092= | synonymous_variant | 17/30 | NP_001349772.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EP300 | ENST00000263253.9 | c.3354C>T | p.Val1118= | synonymous_variant | 18/31 | 1 | NM_001429.4 | ENSP00000263253 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00107 AC: 162AN: 152070Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000919 AC: 231AN: 251414Hom.: 1 AF XY: 0.000883 AC XY: 120AN XY: 135868
GnomAD4 exome AF: 0.00209 AC: 3057AN: 1461858Hom.: 6 Cov.: 33 AF XY: 0.00193 AC XY: 1405AN XY: 727234
GnomAD4 genome AF: 0.00106 AC: 162AN: 152186Hom.: 1 Cov.: 31 AF XY: 0.000753 AC XY: 56AN XY: 74380
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 22, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | EP300: BP4, BP7, BS1 - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 04, 2013 | - - |
EP300-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 22, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at